AZRX

AzurRx BioPharma Stock Price

0.7955
-0.0367 (-4.41%)
Upgrade to Real-Time
Regular Market
0.7955

Low
0.6501

52 Week Range

High
2.63

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
AzurRx BioPharma Inc AZRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0367 -4.41% 0.7955 15:49:11
Open Price Low Price High Price Close Price Prev Close
0.87 0.7801 0.8706 0.8322
Bid Price Ask Price Spread News
0.7901 0.7954 0.0053 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,971 1,477,359 $ 0.8044477 $ 1,188,458 4,181,977 0.6501 - 2.63
Last Trade Time Type Quantity Stock Price Currency
15:49:08 83 $ 0.7955 USD

AzurRx BioPharma Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 59.29M 74.44M 73.60M $ - $ - -1.15 -0.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 1.90%

more financials information »

AzurRx BioPharma News

Date Time Source News Article
4/15/202107:30GlobeNewswire Inc.AzurRx BioPharma CEO Issues Letter to Shareholders
4/09/202106:04Edgar (US Regulatory)Notice of Effectiveness (effect)
4/06/202116:16Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)
4/06/202107:00GlobeNewswire Inc.AzurRx BioPharma Initiates Phase 2 Clinical Trial of..
4/01/202108:01Edgar (US Regulatory)Current Report Filing (8-k)
3/31/202117:27Edgar (US Regulatory)Annual Report (10-k)
3/31/202117:11Seeking AlphaAzurRx slides after MS1819 fails in mid-stage cystic..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AZRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.960.960.78010.87782051,614,042-0.1645-17.14%
1 Month0.961.06990.760.90221563,583,598-0.1645-17.14%
3 Months1.981.990.761.284,141,972-1.18-59.82%
6 Months0.7052.630.67011.475,640,9160.090512.84%
1 Year0.70632.630.65011.442,883,0130.089212.63%
3 Years2.65083.750.3708681.421,100,863-1.86-69.99%
5 Years5.065.600.3708681.46738,526-4.26-84.28%

AzurRx BioPharma Description

AzurRx BioPharma Inc is a development stage biopharmaceutical company. The company is focused on the development of recombinant proteins for the treatment of gastrointestinal diseases and microbiome-related conditions. Its lead product candidate is MS1819, a yeast-derived recombinant lipase for exocrine pancreatic insufficiency (EPI) associated with cystic fibrosis (CF) and chronic pancreatitis (CP).
Your Recent History
NASDAQ
AZRX
AzurRx Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210506 20:04:20